Marco Frigeni

6PUBLICATIONS
60CO-AUTHORS
NanomedicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio

|Jan 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.

Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi

|Sep 09, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

Luca Arcaini, Caroline Besson, Marco Frigeni

Pageof 1

Frequent Collaborators

3 joint publications

Luca Arcaini

3 joint publications

Michele Merli

2 joint publications

Antonio Curti

2 joint publications

Alfonso Piciocchi